To sum up, this study established a model that evaluated BC prognosis on the basis of the PTEN-related ceRNA network, and found that PRLR and CACNA2D1 might be involved in BC by regulating the abundance of tumor immune infiltrating cells and the expression of immune checkpoints, thus affecting the prognosis of BC patients. This evidence concerns the gene CACNA2D1 and breast cancer.